List of Drizalma Sprinkle drug patents

Drizalma Sprinkle is owned by Sun Pharm.

Drizalma Sprinkle contains Duloxetine Hydrochloride.

Drizalma Sprinkle has a total of 4 drug patents out of which 0 drug patents have expired.

Drizalma Sprinkle was authorised for market use on 19 July, 2019.

Drizalma Sprinkle is available in capsule, delayed rel pellets;oral dosage forms.

The generics of Drizalma Sprinkle are possible to be released after 13 April, 2037.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10959982 SUN PHARM Duloxetine sprinkles
Apr, 2037

(14 years from now)

US10413525 SUN PHARM Duloxetine sprinkles
Apr, 2037

(14 years from now)

US9839626 SUN PHARM Duloxetine sprinkles
Apr, 2037

(14 years from now)

US11202772 SUN PHARM Duloxetine sprinkles
Apr, 2037

(14 years from now)

Drugs and Companies using DULOXETINE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 July, 2019

Treatment: NA

Dosage: CAPSULE, DELAYED REL PELLETS;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in